HAVCR2 and Miyoshi myopathy: Our results indicate that dual blockade PD-1/TIM-3 blockade is more effective than single PD-1 or TIM-3 blockade in MM-dia to mitigate BM MM Vγ9Vδ2 T-cell dysfunctions.